Announcements Trials

Browse Landscape

Phase

Phase 3 22 Phase 2/3 1 Phase 1 1

Sponsor

Interventions

pembrolizumab 9 trastuzumab deruxtecan 5 trametinib 4 dabrafenib 4 zanubrutinib 3 nilotinib 3 fludarabine 3 Trastuzumab 3 Dexamethasone 3 Cyclophosphamide 3 tucatinib 2 tisagenlecleucel 2 selinexor 2 relatlimab 2 pemigatinib 2 larotrectinib 2 ipatasertib 2 erdafitinib 2 entrectinib 2 enfortumab vedotin 2 defactinib 2 daratumumab 2 blinatumomab 2 binimetinib 2 belzutifan 2 axicabtagene ciloleucel 2 atezolizumab 2 TIC10 compound 2 Sunitinib 2 Specimen Handling 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

0 trials

Recent Start date Enrollment

Phase 2 × Has announcements × Pemetrexed × Clear all

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡